W. Rathmell
Last active: 11/27/2019

  1. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, Zhao S, Das S, Beckermann KE, Ha L, Rathmell WK, Ancell KK, Balko JM, Bowman C, Davis EJ, Chism DD, Horn L, Long GV, Carlino MS, Lebrun-Vignes B, Eroglu Z, Hassel JC, Menzies AM, Sosman JA, Sullivan RJ, Moslehi JJ, Johnson DB (2018) JAMA Oncol 4(12): 1721-1728
    › Primary publication · 30242316 (PubMed) · PMC6440712 (PubMed Central)
  2. Epigenetic modifiers: activities in renal cell carcinoma. de Cubas AA, Rathmell WK (2018) Nat Rev Urol 15(10): 599-614
    › Primary publication · 30030490 (PubMed)
  3. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell WK (2018) JCI Insight 3(16)
    › Primary publication · 30135306 (PubMed) · PMC6141170 (PubMed Central)
  4. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. Smith CC, Beckermann KE, Bortone DS, De Cubas AA, Bixby LM, Lee SJ, Panda A, Ganesan S, Bhanot G, Wallen EM, Milowsky MI, Kim WY, Rathmell WK, Swanstrom R, Parker JS, Serody JS, Selitsky SR, Vincent BG (2018) J Clin Invest 128(11): 4804-4820
    › Primary publication · 30137025 (PubMed) · PMC6205406 (PubMed Central)
  5. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Gao Q, Liang WW, Foltz SM, Mutharasu G, Jayasinghe RG, Cao S, Liao WW, Reynolds SM, Wyczalkowski MA, Yao L, Yu L, Sun SQ, Fusion Analysis Working Group, Cancer Genome Atlas Research Network, Chen K, Lazar AJ, Fields RC, Wendl MC, Van Tine BA, Vij R, Chen F, Nykter M, Shmulevich I, Ding L (2018) Cell Rep 23(1): 227-238.e3
    › Primary publication · 29617662 (PubMed) · PMC5916809 (PubMed Central)
  6. Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism. Johnson MO, Wolf MM, Madden MZ, Andrejeva G, Sugiura A, Contreras DC, Maseda D, Liberti MV, Paz K, Kishton RJ, Johnson ME, de Cubas AA, Wu P, Li G, Zhang Y, Newcomb DC, Wells AD, Restifo NP, Rathmell WK, Locasale JW, Davila ML, Blazar BR, Rathmell JC (2018) Cell 175(7): 1780-1795.e19
    › Primary publication · 30392958 (PubMed) · PMC6361668 (PubMed Central)
  7. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB, Cancer Genome Atlas Research Network, Camargo F, Liang H (2018) Cell Rep 25(5): 1304-1317.e5
    › Primary publication · 30380420 (PubMed) · PMC6326181 (PubMed Central)
  8. Comprehensive Characterization of Cancer Driver Genes and Mutations. Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H, MC3 Working Group, Cancer Genome Atlas Research Network, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L (2018) Cell 173(2): 371-385.e18
    › Primary publication · 29625053 (PubMed) · PMC6029450 (PubMed Central)
  9. Comprehensive Characterization of Cancer Driver Genes and Mutations. Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Kwok-Shing Ng P, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H, MC3 Working Group, Cancer Genome Atlas Research Network, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L (2018) Cell 174(4): 1034-1035
    › Primary publication · 30096302 (PubMed)
  10. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Kahles A, Lehmann KV, Toussaint NC, Hüser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Cancer Genome Atlas Research Network, Rätsch G (2018) Cancer Cell 34(2): 211-224.e6
    › Primary publication · 30078747 (PubMed)